Session Details
[26PO1-am2]Formulation testing-1/Dispensing, prescription audit and ordering/Drug information-1/Pharmacotherapies (Clinical)-1/(Basics)-1/Risk management/Others
Sat. Mar 26, 2022 10:50 AM - 12:30 PM JST
Sat. Mar 26, 2022 1:50 AM - 3:30 AM UTC
Sat. Mar 26, 2022 1:50 AM - 3:30 AM UTC
[Room PO1] Event Hall Bldg. 1: 1F
【説明時間】11:05～12:15
[26PO1-am2-01]Particle size of inhalation liquid nebulized into a ventilator
○Hirokazu Okamoto1, Yuri Takeda1, Tomoyuki Okuda1 (1. Facul. Pharm., Meijo Univ.)
[26PO1-am2-02]Compatibility of dopamine injection with neonatal parenteral nutrition solutions.
○Kazuhiro Shiota1, Nao Tagawa1,2, Nobuyuki Takahashi1,2, Yoshiaki Fujita3, Syuichi Nawata1,2, Tsutomu Harada3, Tadanori Sasaki1 (1. Department of Pharm., Showa Univ Hosp., 2. Department of Hospital Pharmaceutics., Sch. Pharm., Showa Univ., 3. Division of Pharmaceutics, Department of Pharmacology, Toxicology and Therapeutics., Sch. Pharm., Showa Univ.)
[26PO1-am2-03]Effect of introducing dispensing robots including automatic drug picking equipment in dispensing pharmacies
○Hiroyuki Mizuno1, Yuto Nojiri1, Naoya Yamada1, Kenzo Shibata1, Kazuhiro Nishimura1, Tomohiro Hirose1, Takashi Yanase1 (1. Yanase Pharmacy)
[26PO1-am2-05]Discussion of Preservation Methods for One-Dose Package of Suvorexant Tablets
○Takanori Nakajima1, Soma Ito1, Ran Kikuchi1, Chie Oto1, Misuzu Ota2, Shinji Hidaka3, Yusuke Takizawa1, Takuro Kurita1 (1. Nihon Pharmaceutical Univ., 2. Sanno Hospital, 3. Sch. Pharm., Nihon Univ.)
[26PO1-am2-06]Efforts of the drug dosage adjustment by laboratory data of renal function included on in-hospital prescriptions
○Kaoru Takeuchi1, Masato Hamabashiri1, Erika Miura1, Tadahiro Ikeuchi1, Susumu Kaneshige1, Hidetoshi Kamimura1,2 (1. Department of Pharmacy, Fukuoka University Hospital, 2. Faculty of Pharmaceutical Sciences, Fukuoka University)
[26PO1-am2-07]Efforts for proper use of Recomodulin at Tokai University Hachioji Hospital
○Sae Yoshihra1, Norimitsu Takahashi1, Ippei Mimura1, Masakazu Hayashi1, Shinji Soeda1 (1. Tokai University Hachioji Hospital Pharmaceutical Department)
[26PO1-am2-08S]Study of factors affecting medical incident: Aseptic preparation of anticancer drug (mixing)
○Rina Kanda1, Yuka Miyachi1, Yukina Miyagi1,2, Saori Gocho1,2,3, Chika Nakayama4, Masayuki Ejiri5, Masayuki Takeuchi5, Masafumi Onishi5, Taeyuki Oshima1 (1. College of Pharmacy, Kinjo Gakuin University, 2. Graduate School of Medicine, Aichi Medical University, 3. Department of Pharmacy, Nagoya Ekisaikai Hospital, 4. Faculty of Pharmacy, Gifu University of Medical Science, 5. Department of Pharmacy, Aichi Medical University Hospital)
[26PO1-am2-09]About the role of pharmacists in COVID-19 vaccination at our hospital
○yoichi kudo1, takaaki kiuchi1, yuichi kihira1, chika saito1, ryoji kato1 (1. JR Tokyo General Hospital)
[26PO1-am2-10]Strategic Research for Hospital Formulary in Toda Medical Group (TMG)
○Yoshiko Miyazaki1, Masazumi Ando2, Norihito Kanai2, Mariko Nagase3, Takuya Miyamoto1, Hayato Azuma4, Hikaru Sato5, Nobuhiro Narabu6, Yuta Sawada7, Momoko Shimodate8, Toshio Saito9, Masayoshi Koinuma9,10 (1. Dep. of Pharm.,Toda Cyuo General Hosp., 2. Dep. of Pharm., Niiza Hosp., 3. Dep. of Pharm., Nishitokyo Chuo General Hosp., 4. Dep. of Pharm., Makino Rehabilitation Hosp., 5. Dep. of Pharm., Higashi Tokorozawa Hosp., 6. Dep. of Pharm., TMG Asaka Medical Center, 7. Dep. of Pharm., Matsui Hosp., 8. Dep. of Pharm., Sassa General Hosp., 9. General Incorporated Association TMG Head Office, 10. Fac. of Pharm. Sci., Teikyo Heisei Univ.)
[26PO1-am2-11]Real research for supply to medical staff from the drug information pandemiced COVID-19,2021
○Yoshitaka Ogawa1, Takahiro Sasaki1, Kaori Ito1, Mie Suzuki1, Michiyo Suzuki1, Shinji Soma1,2, Etsuko Ozaki1, Yutaro Iida1,2, Toshiyuki Nakajima3 (1. Department of Pharmaceutical Sciences, IWAKIRI HOSPITAL, 2. Department of Medical IT, IWAKIRI HOSPITAL, 3. Department of Internal Medicine, IWAKIRI HOSPITAL)
[26PO1-am2-12]Analysis of blood levels of caffeine and its metabolite paraxanthine in 23 cases of acute caffeine poisoning
○Yoshitaka Yamazaki1,2, Asuka Mitumoto-Kaizaki1,2, Tadanori Sasaki3, Munetaka Hahyashi4, Kenji Dohi4, Satoshi Numazawa1,2 (1. Showa University School of Pharmacy, 2. Showa University Pharmacological Research Center, 3. Department of Hospital Pharmaceutics, Showa University Hospital, 4. Department of Emergency and Disaster Medicine, Showa University School of Medicine)
[26PO1-am2-13S]Association between SGLT2 inihibitors and pancreatic cancer: Data Mining of a Claims Database
○Yuki Tanaka1, Satoshi Yokoyama1, Kouichi Hosomi1 (1. Kinki university)
[26PO1-am2-14]The risk factors associated with immune checkpoint inhibitor–related pneumonitis
○Mizuho Asada1,2, Takahisa Mikami3, Takahiro Niimura4, Zamami Yoshito5,6, Chuma Masayuyki7, Goda Mitsuhiro4,5, Keisuke Ishizawa4,5, Yoshihiro Uesawa1 (1. Department of Medical Molecular Informatics, Meiji Pharmaceutical University, 2. Department of Pharmacy, Tokyo Medical and Dental University Hospital, 3. Department of Neurology, Tufts Medical Center, 4. Department of Pharmacy, Tokushima University Hospital, 5. Tokushima University Graduate School of Biomedical Sciences, 6. Department of Pharmacy, Okayama University Hospital, 7. Department of Hospital Pharmacy and Pharmacology, Asahikawa Medical University)
[26PO1-am2-15]Comparison of Adverse Event Profiles of Tumor Necrosis Factor-Alfa Inhibitors: Analysis of a Spontaneous Reporting Database
○Kazuma Yamada1, Keiko Hosohata1, Tomohito Wakabayashi1, Tatsuya Iida1, Kazunori Iwanaga1 (1. Faculty of Pharmacy, Osaka Med Pharm Univ.)
[26PO1-am2-16S]Analysis of drug-induced cataract based on FAERS
○Nao Noguchi1, Yoshihiro Uesawa1 (1. Meiji Pharm. Univ.)
[26PO1-am2-17S]Analysis of drug-induced pruritus based on FAERS
○Nakao Yuriko1, Yoshihiro Uesawa1 (1. Meiji Pharm. Univ.)
[26PO1-am2-18S]Analysis of drug-induced pulmonary arterial hypertension using the FDA Adverse Event Reporting System database (FAERS)
○Honoka Nara1, Yoshihiro Uesawa1 (1. Meiji Pharm. Univ.)
[26PO1-am2-19S]Pharmacokinetic alterations of cefazolin in patients with severe trauma
○Ayaka Yumi1, Takafumi Nakano1,2, Kazuhiko Ono1, Saori Tamura1, Junichi Maruyama3, Takuya Ishibashi3, Yasumasa Kawano3, Yoshihiko Nakamura3, Hiroyasu Ishikura3, Toshinobu Hayashi1,2, Takashi Egawa1 (1. Fukuoka Univ.Pharm, 2. Fukuoka Univ.Hosp.Pharm, 3. Fukuoka Univ.Hosp.Emergency Med)
[26PO1-am2-20]Outcome of carbapenem antimicrobial agents by changing the drugs used in Tokai University Hachioji Hospital
○Hisashi Naito1, Masahiro Ozaki1, Yukiko Imai1, Motonari Seki1, Masakazu Hayashi1, Shinji Soeda1 (1. Pharm./ Tokai Univ. Hachioji Hosp.)
[26PO1-am2-22]Assessing the bleeding risk in patients taking Dabigatran for catheter ablation by using eligibility criteria for large clinical trials of Dabigatran
○Yasuyuki Takashima1,2, Minami Ohira3, Kosuke Doki1,4, Masato Homma1,4 (1. Dept. of Pharm. Sci., Graduate School of Comprehensive Human Sciences, Univ. of Tsukuba, 2. T-CReDO, 3. Aisei Pharmacy Co., Ltd., 4. Dept. of Pharm., Univ. of Tsukuba Hosp.)
[26PO1-am2-23]Investigation of antithrombotic therapy for TAVI patoients with atrial fibrillation at Heart Institute of Okayama
○Yuki Maekawa1, Yoshihito Okumura1, Morita Takako1 (1. Department of pharmacy,The Sakakibara Heart Institute of Okayama)
[26PO1-am2-24]Risk factors for neutropenia during the first one year after heart transplantation
○Mai Otokubo1, Kyoichi Wada1, Megumi Ikura2, Takaya Uno2, Kazuki Nakagita2, Naoki Hayakawa2, Takuya Watanabe3, Osamu Seguchi3, Norihide Fukushima3, Tsutomu Nakamura1 (1. Education and Research Center for Clinical Pharmacy, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, 2. Department of Pharmacy, National Cerebral and Cardiovascular Center, 3. Department of Transplant Medicine, National Cerebral and Cardiovascular Center)
[26PO1-am2-25]Case that suffered from a cause search of the sleepiness in the pain control of patients with parvicellular prostate cancer who had the SIADH
○Takashi Nakazawa1, Takeyori Morimoto1, Naotake Maruyama1, Hirohito Beppu1, Toshiyuki Doi1 (1. NHO kyoto medical center)
[26PO1-am2-26S]Effect of acamprosate on Alcohol Relapse Risk Scale (ARRS) in alcohol dependence patients.: A pilot study
○Ayumi Motegi1, Mai Murata1, Ryota Sugihara1, Masahiko Shibuya1, Tomoaki Yamaguchi1, Mitsuru Kimura2, Kohsuke Hayamizu1 (1. Yokohama Univ. Pharm., 2. Kurihama Medical and Addiction Center)
[26PO1-am2-27S]Determination of soluble MICA and FGF-19 level in patient with HCC
○Chieka Suwahara1, Kunihide Mohri1,2, Koji Higai1, Yasuaki Tatsumi1, Noritaka Wakui3, Hidenari Nagai3 (1. Dept. of Medical Biochemistry, Faculty of Pharm. Sci., Toho Univ., 2. Graduate School of Medicine, Toho Univ., 3. Division of Gastroenterology and Hepatology, Depr. of Internal Medicine (Omori), School of Med., Toho Univ.)
[26PO1-am2-28S]Circulating microRNAs as biomarkers for the efficacy of benralizumab in patients with severe asthma
○Takuto Iizuka1, Sekiko Uehara1, Keita Hirai1, Toshihiro Shirai2, Kunihiko Itoh1 (1. Univercity of Shizuoka , 2. Shizuoka General Hospital )
[26PO1-am2-29]Changes in the use of Benzodiazepine/Non-Benzodiazepine by delirium risk countermeasures
○Naomi Katsube1, Kazuki Hara1, Kenichi Ajiki1, Katsuki Yokote1 (1. Shimane Prefectural Central Hospital)
[26PO1-am2-30S]A survey of antipsychotic prescription and dose reduction in inpatients with schizophrenia: managing medications to reduce polypharmacy
○Aoi Matsumoto1, Mariko Nakamura1, Akira Yoshimi1,2,3,4, Hirotake Hida1,3, Shogo Hotta1,3, Norio Ozaki4, Kiyofumi Yamada3, Yukihiro Noda1,2,3,4 (1. Fac and Grad Sch Pharm, Meijo Univ, 2. Clin OMICs and Trans Res Cent, Meijo Univ, 3. Nagoya Univ Hosp Pharm, 4. Grad Sch Med, Nagoya Univ)
[26PO1-am2-31]Effectiveness of polypharmacy measures through the "Project to promote the appropriate use of medicines for the elderly" by the Ministry of Health, Labor and Welfare
○Taijiro Suyama1, Ryoko Kagawa1, Izumi Imataki1, Takuyo Sato1, Hiroshi Shinonaga1, Norikazu Harada1, Tsutomu Kaji1, Mari Mikawa2, Tetsuya Matsunaga3, Yoshihito Goda3, Uematsu Yumiko4, Tatsuya Hujikawa5 (1. Department of Pharmacy,Mitoyo General Hospital, 2. Department of nutritional Management,Mitoyo General Hospital, 3. Department of Rehabilitation,Mitoyo General Hospital, 4. Department of Nursing,Mitoyo General Hospital, 5. Department of ophthalmology, Mitoyo General Hospital)
[26PO1-am2-32]Comparison of prescribing practices between telephone and face-to-face clinics under epidemic and non-epidemic conditions of new coronavirus infections.
○Satoko Katsuragi1,2, Kenji Momo2, Shimamura Hiroshi2,3, Akagawa Keiko2, Nawata Shuichi2,3, Sasaki Tadanori3 (1. Showa University Hospital East Branch, 2. Showa University, 3. Showa University Hospital)
[26PO1-am2-33]MARTA olanzapine-induced toxicity and sex differences
○Natsumi Hattori-Usami1,2, Asuka Kaizaki-Mitsumoto1,2, Satoshi Numazawa1,2 (1. Pharm. Sci., Showa Univ., 2. SUPRC)
[26PO1-am2-34]Blood protein profiling after transient cerebral ischemia in mice
○Saki Egashira1, Takafumi Nakano1,3, Yui Tagashira1, Yoshihiko Nakamura2, Yukiomi Eguchi1,3, Fuyuki Kametani4, Masato Hosokawa1,4, Tomomitsu Satho1, Keiichi Irie1, Yuta Yamashita1, Kazunori Sano1, Kenichi Mishima1 (1. Dept. pharmacol. Fukuoka Univ., 2. Dept. medical. Fukuoka Univ., 3. Dept. pharm. Fukuoka Univ. Hosp., 4. Tokyo metroplitan institute of Medical Sci.)
[26PO1-am2-35]Therapeutic effects of anti-HMGB1 antibody in delayed phase of cerebral ischemia in a mouse model of middle cerebral artery occlusion
○Yui Tagashira1, Saki Egashira1, Mayuka Morimoto1, Yukiomi Eguchi1,2, Takafumi Nakano1,2, Keiichi Irie1, Masato Hosokawa1, Yuta Yamashita1, Kazunori Sano1, Kenichi Mishima1 (1. Fukuoka Univ. Pharm., 2. Fukuoka Univ. Hosp. Pharm.)
[26PO1-am2-36]Effects of ninjin'yoeito on muscle atrophy in aging C57BL/6J mice.
○Takeshi Suginohara1, Megumi Kawaguchi1, Marisa Kaneda1, Seiwa Michihara1, Likun Han1, Nina Fujita1, Ryuji Takahashi1 (1. Kracie Pharma, Ltd. Kampo Research Labs.)
[26PO1-am2-37]Yokukansankachimpihange ameliorates Memantine Hydrochloride-induced Dizziness in Mice with Memory Impairment
○Taiki Shimoyama1, Yayoi Aoki1, Marisa Kaneda1, Likun Han1, Seiwa Michihara1, Ryuji Takahashi1 (1. Kracie Pharma. Ltd.)
[26PO1-am2-38S]Role of Zinc in NSAIDs-Induced Small Intestinal Injury in mice
○Yuuki Otsuka1, Hina Kijima1, Rikako Nakai1, Hiroyuki Yasui3, Kikuko Amagase1,2 (1. Lab. of Pharmacol. & Pharmacother., College of Pharm. Sci. Ritsumeikan Univ., 2. Lab. of Pharmacol. & Pharmacother., Grad. Sch. of Pharmacy, Ritsumeikan Univ.,, 3. Kyoto Pharm. Univ.)
[26PO1-am2-39]The therapeutic effect of low-fat diet on rats in the early developmental stage of type2 diabetes model
○Saori Tanaka1, Yurina Chikazawa1, Syoutarou Yamazoe1, Hitoshi Matsumura1 (1. Osaka Medical and Pharm. Univ.)
[26PO1-am2-40]Protective effect of endogenous apelin against retinal dysfunction in a mouse model of type 1 diabetes
○Yuki Ishimaru1, Masato Mikazuki1, Yurina Okamoto1, Yume Naiki1, Yuka Fukuoka1, Akiko Yamamuro1, Yasuhiro Yoshioka1, Sadaaki Maeda1 (1. Fac. Pharmaceut. Sci., Setsunan Univ.)
[26PO1-am2-41]Exon skipping of Pax6 induced by splicing-modifying-compounds in MIN6 cells
○Yukihiko Maeda1, Tomoko Tanaka1, Kenji Ohe2, Shohta Kodama1 (1. Dept. of Regene. and Transplant., Fac. of Med., Fukuoka Univ., 2. Fac. of Pharm. Sci., Fukuoka Univ.)
[26PO1-am2-42]Circadian rhythm of xanthine oxidoreductase activity and its protein expression in rat liver and plasma
○Yoshitaka Tayama1, Shizuko Maeda1, Kenji Tanabe1, Yurika Okamura2, Kazumi Sugihara1, Katsushi Miyake1 (1. Department of Pharm. Sci, Hiroshima International Univ., 2. Department of Clinical Nutrition, Hiroshima International Univ.)
[26PO1-am2-43S]Pathogenesis of irinotecan-induced mucositis in mice
○Hikaru Otsuki1, Ayana Fujiwara2, Kikuko Amagase1,2 (1. Lab. of Pharmacol. & Pharmacother., Grad. Sch. of Pharmacy, Ritsumeikan Univ.,, 2. Lab. of Pharmacol. & Pharmacother., College of Pharm. Sci., Ritsumeikan Univ.)
[26PO1-am2-44]Role of Ezrin/Radixin/Moesin in the surface localization of Programmed Death Ligand-1 in LS180 cells
○Takuro Kobori1, Honami Ishikawa1, Yui Ito1, Rina Doukuni1, Chihiro Tanaka1, Mayauka Tameishi1, Yoko Urashima1, Takuya Ito1, Tokio Obata1 (1. Facult. Pharm., Osaka Ohtani Univ.)
[26PO1-am2-45S]Involvement of Ezrin/Radixin in the surface expression of Programmed Death Ligand-1 in KP-2 cells
○Rina Doukuni1, Chihiro Tanaka1, Mayuka Tameishi1, Honami Ishikawa1, Yui Ito1, Takuro Kobori1, Yoko Urashima1, Takuya Ito1, Tokio Obata1 (1. Facult. Pharm., Osaka Ohtani Univ.)
[26PO1-am2-46]Transcriptional Regulation of ULBP-1 of NKG2D ligands
○Honoka Kosuge1, Koji Higai1 (1. Dept. of Medical Biochemistry, Faculty of Pharmaceutical Sciences Toho University)
[26PO1-am2-47]Effect of the CDK9 inhibitor on cell death in adult T-cell leukemia related cell lines .
○Naho Kato1, Tomohiro Kozako1, Takeo Ohsugi2, Akiyoshi Aikawa1, Shin-ichiro Honda1 (1. Facul. of Pharm. Sci., Fukuoka Univ., 2. Sch. of Vet.Med., Rakunogakuen Univ.)
[26PO1-am2-48]Effects of drug preparation by non-pharmacists on the occurrence of incidents and accidents
○Takahiro Ito1, Masato Yoshida1, Kento Mitani1, Hidenori Hayashi1, Hiroshi Toda1, Yosuke Mano1, Takahiro Yamada1, Masaya Ishikawa2, Hiroshi Tanaka1, Atsushi Mori1 (1. MIC Inc. Chubu Region 1st Block, 2. MIC Inc. Department of Pharmaceutical Management)
[26PO1-am2-49S]The relationship between antihypertensive medication and falls in an acute care hospital
○Mayu Suzukawa1, Haruki Ishikawa1, Minae Isawa1, Mayumi Mochizuki1, Daisuke Fujisawa2, Tohru Aomori1,3 (1. Keio Univ. Fac. Pharm., 2. Keio Univ. Fac. Med., 3. Keio Univ. Hosp. Dep. Pharm.)
[26PO1-am2-50]Exposure measures in our hospital's transcatheter arterial chemoembolization therapy and handling of volatile anticancer drugs
○Chinami Harada1, Kei Miyagi1, Hiroko Tsuchimoto1, Maho Ishii3, Takahiro Fujimoto3, Nanami Ishii3, Maho Kikuta3, Shinsaku Kimura2, Akifumi Iwaki1 (1. Chibune General Hospital, 2. Takatsuki General Hospital, 3. Department of Pharmacology, Setsunan University Faculty of Pharmaceutical Sciences)
[26PO1-am2-51]The adsorption of arbekacin by the AN69ST membrane
-Using an assay of arbekacin by the TNP derivatization-
○Yoshinori Inano1, Kayoko Tsuchiya1, Ryouta Kumano1, Go Miura2, Hiromitsu Nakasa1,3 (1. Division of Pharmacy, Eastern Chiba Medical Center, 2. Laboratory of Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, Josai International University, 3. Department of General Medical Sciences, Graduate School of Medicine, Chiba University)
[26PO1-am2-52]A pilot study to search for biomarkers that contribute to the evaluation of cancer treatment using blood samples before and after Heavy Ion Radiotherapy.
○Toshiki Aiba1, Makoto Shinoto1, Takashi Imai1, Hirotoshi Takiyama1, Shigeru Yamada1, Shizuko Kakinuma1 (1. Quantum Life and Medical Science Directorate,National Institutes for Quantum Science and Technology)
[26PO1-am2-53]Development of AI chatbot to support Clostridioides difficile infection (CDI) checkup and therapeutics
○Masahiro Kobayashi1, Nana Yokoyama1 (1. Kitasato Univ.)
[26PO1-am2-54]Change of the preparation time in Drug Vial Optimization for Bevacizumab Injection
○Yurika yoshino1, Misaki Uchikawa1, junichi Mukai1, Michiko Yamada1, Nakaba Okamura1, Rie Kubota1 (1. Clinical Pharmacy Education. Center for Clinical Pharmacy and Sciences. Kitasato University School of Pharmacy)
[26PO1-am2-55]Use of ozone water for degradation and inactivation of antineoplastic drugs
○Ginjiro Kato1, Hidemichi Mitome1, Miho Shimasaki1, Kenichiro Teshima1, Kanako Tawa1, Tomotaka Tanabe1, Tatsuya Funahashi1, Noriyuki Hatae2, Yasumasa Koike3, Masafumi Hasebe3, Noriaki Hidaka4, Mamoru Tanaka4, Kazuki Akira1 (1. Col. Pharm. Sci., Matsuyama Univ., 2. Yokohama Univ. Pharm., 3. Div. Pharm., Nat. Hosp. Org. Shikoku Cancer Center., 4. Div. Pharm., Ehime Univ. Hosp. )
[26PO1-am2-56S]Development of a new method for prevention and improvement of side effects and stress during paclitaxel/carboplatin therapy by using virtual reality: A case study
○Misaki Arai1, Kazuyuki Niki1,2, Yutaka Ueda3, Satoshi Nakagawa3, Ayaka Morimoto4, Tadashi Kimura3, Mikiko Ueda1,2 (1. Sch. Pharm. Sci., Osaka Univ., 2. Grad. Sch. Pharm. Sci., Osaka Univ., 3. Grad. Sch. Med., Osaka Univ., 4. Dept. of Pharm. Osaka Univ. Hosp.)
[26PO1-am2-57]About the drug information cooperation document at the time of discharge required by the insurance pharmacy pharmacist
○Yuko Aoshima1, Hirozi Totuka1, Kenzi Ide1 (1. Omaezaki Municipal Hospital)
[26PO1-am2-59]Adverse reactions investigation to COVID-19 virus vaccination of healthcare workers in Teikyo University Hospital
○Hiroshi Yoshikawa1, Kohei Harai1, kazumi tani2, Yoshiharu Mitsunaga1, Tamaki Watanabe1,2, Takeshi Kawamura1,2, Masao Tsuchiya1, Nobuhiro Yasuno1,2 (1. Department of Pharmacy Teikyo University Hospital , 2. Faculty of Pharmaceutical Sciences Teikyo University )